Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)

Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)

Background: Pulmonary arterial hypertension (PAH) is a malignant pulmonary vascular disease that negatively impacts quality of life, exercise capacity, and mortality. This study sought to investigate the relationship between serum uric acid (UA) level and the disease severity and treatment response...

Full description

Bibliographic Details
Main Authors: Jun Luo, Yuanchang Li, Jingyuan Chen, Haihua Qiu, Wenjie Chen, Xiaoqin Luo, Yusi Chen, Yingjie Tan, Jiang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Pharmacology
Subjects:
uric acid
congenital heart disease
pulmonary arterial hypertension
eisenmenger syndrome
risk stratification
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1238581/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1238581/full

Similar Items